NCT00788671View on ClinicalTrials.gov

Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

November 3, 2008

Primary Completion Date

June 10, 2016

Study Completion Date

November 30, 2027

Conditions
Atypical Endometrial HyperplasiaStage I Uterine Corpus Cancer AJCC v7Stage IA Uterine Corpus Cancer AJCC v7Stage IB Uterine Corpus Cancer AJCC v7Stage II Uterine Corpus Cancer AJCC v7
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

DEVICE

Levonorgestrel-Releasing Intrauterine System

Undergo placement of a levonorgestrel-releasing intrauterine system

OTHER

Quality-of-Life Assessment

Ancillary studies

Trial Locations (7)

77030

M D Anderson Cancer Center, Houston

77054

The Woman's Hospital of Texas, Houston

77058

MD Anderson League City, Nassau Bay

77094

MD Anderson in Katy, Houston

77384

MD Anderson in The Woodlands, The Woodlands

77478

MD Anderson in Sugar Land, Sugar Land

77026-1967

Lyndon Baines Johnson General Hospital, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER